Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

GJ Morgan, FE Davies, WM Gregory, SE Bell, AJ Szubert, NN Coy, G Cook, S Feyler, PRE Johnson, C Rudin, Mark Drayson, RG Owen, FM Ross, NH Russell, GH Jackson, JA Child

Research output: Contribution to journal › Article

130 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results'. Together they form a unique fingerprint.

Medicine & Life Sciences